Hepatitis B
High Rate of New Hepatitis B Among African-Americans, Study Finds
- Details
- Category: HBV Epidemiology & Mortality
- Published on Wednesday, 11 September 2013 00:00
- Written by Liz Highleyman
Black Americans have a higher incidence of hepatitis B virus (HBV) infection than any other racial/ethnic group, including Asian-Americans, according to a review article in the July 1, 2013, advance edition of Clinical Gastroenterology and Hepatology.
Human Stem Cells Used to Create Functional Liver Cells in Mice
- Details
- Category: Liver Transplant - HBV
- Published on Wednesday, 07 August 2013 00:00
- Written by Liz Highleyman
Researchers have discovered a way to generate functional hepatocytes (liver cells) from human stem cells, which worked as expected and increased survival when transplanted into mice with acute liver injury, researchers reported in the July 9, 2013, advance online edition of Stem Cells and Development.
IAS 2013: Many People Need Hepatitis B Treatment in the Gambia
- Details
- Category: HBV Treatment
- Published on Monday, 15 July 2013 00:00
- Written by Liz Highleyman
About 8% of people tested through a community-based screening program in the Gambia have hepatitis B, and about 8% of these have advanced liver disease and meet European criteria for antiviral therapy, according to a report presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
Hepatitis B Treatment with Entecavir Lowers Risk of Liver Cancer
- Details
- Category: HBV Treatment
- Published on Thursday, 01 August 2013 00:00
- Written by Liz Highleyman
Long-term treatment with entecavir (Baraclude) significantly reduces the chances of developing hepatocellular carcinoma compared with no treatment, and appears to lower the risk more than an older drug, especially for the most at-risk patients, according to a report in the July 2013 issue of Hepatology.
DDW 2013: Does HBV Suppression Prevent Liver Disease Progression?
- Details
- Category: HBV Treatment
- Published on Wednesday, 19 June 2013 00:00
- Written by Liz Highleyman
Chronic hepatitis B patients with cirrhosis may still experience liver disease progression even if they undergo antiviral treatment and achieve good virological response, according to a poster presented at the Digestive Disease Week meeting (DDW 2013) last month in Orlando.
July 28 Is World Hepatitis Day
- Details
- Category: Hepatitis B
- Published on Sunday, 28 July 2013 00:00
- Written by Liz Highleyman
Sunday, July 28, is World Hepatitis Day, an opportunity to raise awareness about viral hepatitis and its consequences. The World Hepatitis Alliance theme for 2013 -- See No Evil, Hear No Evil, Speak No Evil -- emphasizes that hepatitis B and C are receiving inadequate attention worldwide, despite the large number of people affected and the high burden on healthcare systems.
Low Vitamin D Linked to Greater Hepatitis B Virus Replication
- Details
- Category: HBV Disease Progression
- Published on Thursday, 13 June 2013 00:00
- Written by Liz Highleyman
Low blood levels of 25-hydroxyvitamin D were strongly associated with higher hepatitis B virus (HBV) viral load in a study of more than 200 untreated patients described in the May 22, 2013 advance online edition of Hepatology.
WHO Releases Global Policy Report on Prevention and Control of Viral Hepatitis
- Details
- Category: Hepatitis B
- Published on Sunday, 28 July 2013 00:00
- Written by Liz Highleyman
In advance of World Hepatitis Day (June 28), the World Health Organization (WHO) this week released its first country-by-country hepatitis survey, covering viral hepatitis prevention and control efforts in 126 member states.
DDW 2013: Tenofovir and Entecavir Effectively Suppress Hepatitis B Virus
- Details
- Category: HBV Treatment
- Published on Thursday, 06 June 2013 00:00
- Written by Liz Highleyman
The newer antivirals tenofovir (Viread) and entecavir (Baraclude) inhibit hepatitis B virus (HBV) replication more effectively than older agents, but good adherence is needed to maintain long-term viral suppression, according to a set of studies presented at the Digestive Disease Week meeting (DDW 2013) last month in Orlando.
More Articles...
- Coverage of Digestive Disease Week 2013
- EASL 2013: Do Asian Patients Respond Better to Pegylated Interferon for Hepatitis B?
- EASL 2013: Truvada Works Best for Immune-Tolerant Hepatitis B Patients -- But Do They Need Treatment?
- Coverage of the 2013 EASL International Liver Congress
- EASL 2013: Long-term Tenofovir Reduces Liver Cancer Risk in People with Chronic Hepatitis B
Web Design and Development by